Evidence map›Paper›PMID 38928430›Full record

ArticleInternational journal of molecular sciences2024

Arsenic Nanoparticles Trigger Apoptosis via

Alejandra A Covarrubias, Mauricio Reyna-Jeldes, Seidy Pedroso-Santana, Sabrina Marín, Carolina Madero-Mendoza, Cecilia Demergasso, Claudio Coddou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alejandra A CovarrubiasDepartamento de Ciencias Biomédicas, Facultad de Medicina, Universidad Católica del Norte, Coquimbo 1781421, Chile.
Mauricio Reyna-JeldesDepartamento de Ciencias Biomédicas, Facultad de Medicina, Universidad Católica del Norte, Coquimbo 1781421, Chile.ORCID 0000-0002-5842-9307
Seidy Pedroso-SantanaNúcleo para el Estudio del Cáncer a Nivel Básico, Aplicado y Clínico, Universidad Católica del Norte, Coquimbo 1781421, Chile.ORCID 0000-0002-2060-1247
Sabrina MarínNúcleo para el Estudio del Cáncer a Nivel Básico, Aplicado y Clínico, Universidad Católica del Norte, Coquimbo 1781421, Chile.
Carolina Madero-MendozaCarrera de Medicina, Facultad de Medicina y Odontología, Universidad de Antofagasta, Antofagasta 1200000, Chile.
Cecilia DemergassoNúcleo para el Estudio del Cáncer a Nivel Básico, Aplicado y Clínico, Universidad Católica del Norte, Coquimbo 1781421, Chile.ORCID 0000-0003-4563-3066
Claudio CoddouDepartamento de Ciencias Biomédicas, Facultad de Medicina, Universidad Católica del Norte, Coquimbo 1781421, Chile.ORCID 0000-0002-5297-3694

Funding

Agencia Nacional de Investigación y Desarrollo Becas Chile Scholarship for Doctoral studies 72220004Agencia Nacional de Investigación y Desarrollo FONDEQUIP EQM 140100Agencia Nacional de Investigación y Desarrollo Millennium Nucleus for the Study of Pain (MiNuSPain)FIC Antofagasta 40013423-0VRIDT, UCN Núcleo para el estudio del cáncer a nivel básico, aplicado, y clínico
6 · The paper itself

Abstract

Arsenic compounds have been used as therapeutic alternatives for several diseases including cancer. In the following work, we obtained arsenic nanoparticles (AsNPs) produced by an anaerobic bacterium from the

Indexed as

AnoikisApoptosisArsenicNanoparticlesCaspase 3Cell Line, TumorCell SurvivalHumansMouth NeoplasmsProto-Oncogene Proteins c-aktSignal TransductionTumor Suppressor Protein p53ArsenicCaspase 3Proto-Oncogene Proteins c-aktTumor Suppressor Protein p53anoikisapoptosisarsenic nanoparticlesBit-1OECM-1squamous cell carcinoma

Identifiers

PMID38928430
PMCPMC11204275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.